Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2025-12-25 @ 1:06 AM
NCT ID:
NCT03450993
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with documented recurrent symptomatic PAF.
* Currently on stable medical therapy for AF and willing to continue on the same treatment regimen while participating in the study.
* No current daily practice of yoga, meditation, guided imagery or other techniques that elicit the RR.
* Able to provide informed consent and to understand written and spoken English.
Exclusion Criteria:
* Allergy to adhesives that prevents wearing the HRV monitor.
* Patients unable or unwilling to participate in an intervention delivered via video conferencing.
* End Stage renal failure or heart failure, severe unstable medical or psychiatric disease.
* Patients deemed unable to complete protocol due to cognitive or other reasons.
* Patients on psychoactive medications will have eligibility determined by the PI or MD co-investigator on a case-by-case basis, and will be admitted to the study if medication is deemed stable
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT03450993
Study Brief:
Protocol Section:
NCT03450993